Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
Triple-negative breast cancer (TNBC) is an aggressive breast type of cancer with no expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). It is a highly metastasized, heterogeneous disease that accounts for 10–15% of total breast cance...
Main Authors: | Sylvia Annabel Dass, Kim Liu Tan, Rehasri Selva Rajan, Noor Fatmawati Mokhtar, Elis Rosliza Mohd Adzmi, Wan Faiziah Wan Abdul Rahman, Tengku Ahmad Damitri Al-Astani Tengku Din, Venugopal Balakrishnan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/57/1/62 |
Similar Items
-
The Unique Biology behind the Early Onset of Breast Cancer
by: Alaa Siddig, et al.
Published: (2021-03-01) -
A clinicopathologic study of triple negative breast cancer
by: Vandana L Gaopande, et al.
Published: (2015-01-01) -
Microvessel density and vascular endothelial growth factor receptors in breast carcinoma under the influence of rapamycin and platelet factor 4
by: Muhammad Shahidan Muhammad Sakri, et al.
Published: (2020-01-01) -
Platinum chemotherapy for early triple-negative breast cancer
by: Sofia RE. Mason, et al.
Published: (2024-06-01) -
Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
by: Srijan Basu, et al.
Published: (2023-11-01)